Phathom Pharmaceuticals Inc banner

Multiples-Based Value

The Multiples-Based Value for Phathom Pharmaceuticals Inc (PHAT) under the Base Case is 18.036 USD. Compared with the current market price of 5.915 USD, the stock appears Undervalued by 67% .

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PHAT Multiples-Based Value
Base Case
$18.036
Undervaluation 67%
Multiples-Based Value
Price $5.915

Multiples Across Competitors

PHAT Competitors Multiples
Phathom Pharmaceuticals Inc Competitors